Vir Biotechnology Stock Target Price and Analyst Consensus
| VIR Stock | USD 7.15 0.15 2.14% |
The current analyst and expert consensus on Vir Biotechnology is Buy, with 2 strong buy opinions. The current projected Vir Biotechnology target price consensus is 31.13 with 9 analyst opinions. Check out Macroaxis Advice on Vir Biotechnology to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. To learn how to invest in Vir Stock, please use our How to Invest in Vir Biotechnology guide.The most common way Vir Biotechnology analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Vir Biotechnology executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Vir Biotechnology. We strongly encourage you to use your own analysis of Vir Biotechnology to validate this buy or sell advice. Vir Biotechnology buy-or-sell recommendation module provides average expert sentiment on the projected Vir Biotechnology target price to derive its highest and lowest estimates based on projected price volatility of 8.4662.
Lowest Forecast 28.32 | Highest Forecast 34.55 | Target Price 31.13 |
Vir |
It's important to approach Vir Biotechnology's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Vir Biotechnology Target Price Consensus
Vir target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Vir Biotechnology's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 9 | Buy |
Most Vir analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Vir stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Vir Biotechnology, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationVir Biotechnology Target Price Projection
Vir Biotechnology's current and average target prices are 7.15 and 31.12, respectively. The current price of Vir Biotechnology is the price at which Vir Biotechnology is currently trading. On the other hand, Vir Biotechnology's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Vir Biotechnology Market Quote on 15th of March 2025
Target Price
Analyst Consensus On Vir Biotechnology Target Price
Vir Biotechnology Analyst Ratings
Vir Biotechnology's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Vir Biotechnology stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Vir Biotechnology's financials, market performance, and future outlook by experienced professionals. Vir Biotechnology's historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Vir Biotechnology price targets
Vir Biotechnology's stock target price is an estimate of its future price, usually made by analysts. Using Vir Biotechnology's target price to determine if it is a suitable investment can be done through the following steps:- Look at Vir Biotechnology's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Vir Biotechnology's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Vir Biotechnology Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Vir Biotechnology is a key component of Vir Biotechnology valuation and have some predictive power on the future returns of a Vir Biotechnology.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Warren Buffett Holdings Invested few shares | |
 | Momentum Invested few shares | |
 | Hedge Favorites Invested few shares | |
 | Cash Cows Invested few shares | |
 | Driverless Cars Invested over 60 shares | |
 | SRI Sustainable Growth Invested over 40 shares | |
 | Apparel Invested over 40 shares | |
 | Casinos Sold over 90 shares | |
 | Macroaxis Index Sold over 90 shares | |
 | Utilities Invested over 90 shares | |
Additional Tools for Vir Stock Analysis
When running Vir Biotechnology's price analysis, check to measure Vir Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vir Biotechnology is operating at the current time. Most of Vir Biotechnology's value examination focuses on studying past and present price action to predict the probability of Vir Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vir Biotechnology's price. Additionally, you may evaluate how the addition of Vir Biotechnology to your portfolios can decrease your overall portfolio volatility.